These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Recent advances in developing vaccines against Toxoplasma gondii: an update. Zhang NZ; Wang M; Xu Y; Petersen E; Zhu XQ Expert Rev Vaccines; 2015; 14(12):1609-21. PubMed ID: 26467840 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of three recombinant multi-antigenic vaccines composed of surface and secretory antigens of Toxoplasma gondii in murine models of experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Grzybowski M; Dlugonska H Vaccine; 2011 Jan; 29(4):821-30. PubMed ID: 21087690 [TBL] [Abstract][Full Text] [Related]
4. Nucleic acid vaccination against Toxoplasma gondii in mice. Angus CW; Klivington D; Wyman J; Kovacs JA J Eukaryot Microbiol; 1996; 43(5):117S. PubMed ID: 8822899 [No Abstract] [Full Text] [Related]
5. The virulence-related rhoptry protein 5 (ROP5) of Toxoplasma Gondii is a novel vaccine candidate against toxoplasmosis in mice. Zheng B; Lu S; Tong Q; Kong Q; Lou D Vaccine; 2013 Sep; 31(41):4578-84. PubMed ID: 23928460 [TBL] [Abstract][Full Text] [Related]
6. Construction and immunogenicity of pseudotype baculovirus expressing Toxoplasma gondii SAG1 protein in BALB/c mice model. Fang R; Feng H; Nie H; Wang L; Tu P; Song Q; Zhou Y; Zhao J Vaccine; 2010 Feb; 28(7):1803-7. PubMed ID: 20018269 [TBL] [Abstract][Full Text] [Related]
7. GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii. Jongert E; de Craeye S; Dewit J; Huygen K Parasite Immunol; 2007 Sep; 29(9):445-53. PubMed ID: 17727568 [TBL] [Abstract][Full Text] [Related]
8. Toxoplasma gondii: the vaccine potential of three trivalent antigen-cocktails composed of recombinant ROP2, ROP4, GRA4 and SAG1 proteins against chronic toxoplasmosis in BALB/c mice. Dziadek B; Gatkowska J; Grzybowski M; Dziadek J; Dzitko K; Dlugonska H Exp Parasitol; 2012 May; 131(1):133-8. PubMed ID: 22445587 [TBL] [Abstract][Full Text] [Related]
9. DNA vaccine encoding the Toxoplasma gondii bradyzoite-specific surface antigens SAG2CDX protect BALB/c mice against type II parasite infection. Zhang M; Zhao L; Song J; Li Y; Zhao Q; He S; Cong H Vaccine; 2013 Sep; 31(41):4536-40. PubMed ID: 23933373 [TBL] [Abstract][Full Text] [Related]
10. Toxoplasma gondii: immunogenicity and protection by P30 peptides in a murine model. Siachoque H; Guzman F; Burgos J; Patarroyo ME; Gomez Marin JE Exp Parasitol; 2006 Sep; 114(1):62-5. PubMed ID: 16545806 [TBL] [Abstract][Full Text] [Related]
11. Veterinary vaccines against Toxoplasma gondii. Innes EA; Bartley PM; Maley S; Katzer F; Buxton D Mem Inst Oswaldo Cruz; 2009 Mar; 104(2):246-51. PubMed ID: 19430650 [TBL] [Abstract][Full Text] [Related]
12. Modulation of immune response to Toxoplasma gondii in sheep by immunization with a DNA vaccine encoding ROP1 antigen as a fusion protein with ovine CD154. Hiszczyńska-Sawicka E; Li H; Xu JB; Holec-Gąsior L; Kur J; Sedcole R; Bickerstaffe R; Stankiewicz M Vet Parasitol; 2011 Dec; 183(1-2):72-8. PubMed ID: 21742437 [TBL] [Abstract][Full Text] [Related]
13. Immunological response of sheep to injections of plasmids encoding Toxoplasma gondii SAG1 and ROP1 genes. Li B; Oledzka G; McFarlane RG; Spellerberg MB; Smith SM; Gelder FB; Kur J; Stankiewicz M Parasite Immunol; 2010; 32(9-10):671-83. PubMed ID: 20691019 [TBL] [Abstract][Full Text] [Related]
14. A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts. Beghetto E; Nielsen HV; Del Porto P; Buffolano W; Guglietta S; Felici F; Petersen E; Gargano N J Infect Dis; 2005 Feb; 191(4):637-45. PubMed ID: 15655789 [TBL] [Abstract][Full Text] [Related]
15. Toxoplasma gondii: protective immunity induced by rhoptry protein 9 (TgROP9) against acute toxoplasmosis. Chen J; Zhou DH; Li ZY; Petersen E; Huang SY; Song HQ; Zhu XQ Exp Parasitol; 2014 Apr; 139():42-8. PubMed ID: 24602875 [TBL] [Abstract][Full Text] [Related]
16. Toxoplasma gondii: the immunogenic and protective efficacy of recombinant ROP2 and ROP4 rhoptry proteins in murine experimental toxoplasmosis. Dziadek B; Gatkowska J; Brzostek A; Dziadek J; Dzitko K; Dlugonska H Exp Parasitol; 2009 Sep; 123(1):81-9. PubMed ID: 19508869 [TBL] [Abstract][Full Text] [Related]
17. Toxoplasma gondii: chimeric Dr fimbriae as a recombinant vaccine against toxoplasmosis. Gatkowska J; Gasior A; Kur J; Dlugonska H Exp Parasitol; 2008 Feb; 118(2):266-70. PubMed ID: 17825290 [TBL] [Abstract][Full Text] [Related]
18. DNA immunization with eukaryotic initiation factor-2α of Toxoplasma gondii induces protective immunity against acute and chronic toxoplasmosis in mice. Chen J; Huang SY; Zhou DH; Li ZY; Petersen E; Song HQ; Zhu XQ Vaccine; 2013 Dec; 31(52):6225-31. PubMed ID: 24183979 [TBL] [Abstract][Full Text] [Related]
19. Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts. Nielsen HV; Di Cristina M; Beghetto E; Spadoni A; Petersen E; Gargano N Exp Parasitol; 2006 Apr; 112(4):274-9. PubMed ID: 16368092 [TBL] [Abstract][Full Text] [Related]
20. Protective immunity induced by a DNA vaccine expressing eIF4A of Toxoplasma gondii against acute toxoplasmosis in mice. Chen J; Huang SY; Li ZY; Yuan ZG; Zhou DH; Petersen E; Zhang NZ; Zhu XQ Vaccine; 2013 Mar; 31(13):1734-9. PubMed ID: 23370151 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]